- Sputnik International, 1920
World
Get the latest news from around the world, live coverage, off-beat stories, features and analysis.

Critics of Russia’s Sputnik V Vaccine Went Silent After Successful Phase 3 Trials, RDIF Says

© Press Service of the Ministry of Health of the Russian Federation / Go to the mediabankIn this handout photo released by Russian Healthcare Ministry, packs with the world's first vaccine against COVID-19 registered in Russia are pictured, in Moscow, Russia
In this handout photo released by Russian Healthcare Ministry, packs with the world's first vaccine against COVID-19 registered in Russia are pictured, in Moscow, Russia - Sputnik International, 1920, 02.02.2021
Subscribe
International
India
MOSCOW (Sputnik) - Those who are doubtful of Russia’s Sputnik V vaccine now have no more reasoning for criticism as the phase 3 trials have proved the vaccine's efficacy, as evidenced by a publication in the Lancet medical journal, CEO of Russian Direct Investment Fund (RDIF) Kirill Dmitriev said on Tuesday.

The Sputnik V vaccine is 91.6 percent efficient against symptomatic COVID-19, according to an interim analysis of the results of the phase 3 trials published earlier in the day in Lancet, one of the most reputable peer-reviewed medical journals.

In this handout photo released by Hungarian Foreign Ministry, a laboratory assistant holds a phial with Russia's coronavirus vaccine Gam-COVID-Vac, trade-named Sputnik V, in Budapest, Hungary - Sputnik International, 1920, 02.02.2021
Science & Tech
'Vaccine for All Mankind': Lancet Article Validates Sputnik V Efficacy at 91.6%
"Many had doubts, but the article in Lancet provides the data and gives answers to all questions. It is very important, this is the most powerful watershed. We see that the critics have been going silent recently because there is nothing for them to pick on," Dmitriev said.

Sputnik V is the world's first coronavirus vaccine officially registered for emergency use in Russia on 11 August. In December, Russia launched large-scale coronavirus immunisation.

Russia produces the vaccine for domestic use on its own. It has also struck agreements with a number of foreign manufactures to produce doses for exports. The RDIF is leading efforts to promote the Russian vaccine abroad.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала